Communicable Diseases: all 4,447 studies

Page 8 of 45. Open to participants first (513), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)CompletedNCT03366207Phase 4Results posted
• LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)TerminatedNCT03354754Phase 2Results posted
• Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult WomenCompletedNCT03354598Phase 3Results posted
• Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated InfectionCompletedNCT03349268Not applicableResults posted
• Placebo-Controlled Trial of Antibiotic Therapy in Adults With Suspect Lower Respiratory Tract Infection (LRTI) and a Procalcitonin LevelTerminatedNCT03341273Not applicableResults posted
• Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120)CompletedNCT03336502Phase 1Results posted
• A Long-term Follow-up Study to Evaluate the Impact of Lumicitabine on the Incidence of Asthma and/or Wheezing in Infants and Children With a History of Respiratory Syncytial Virus InfectionCompletedNCT03332459Phase 2Results posted
• A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.CompletedNCT03329092Phase 3Results posted
• Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy AdultsCompletedNCT03321968Phase 3Results posted
• Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in AdultsCompletedNCT03301051Phase 3Results posted
• Dose Ranging Study of the Safety and Efficacy of Orally Administered Lyophilized Fecal Microbiota Product (PRIM-DJ2727) for the Treatment of Recurrent Clostridium Difficile Infection (CDI)TerminatedNCT03298048Phase 2Results posted
• Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)CompletedNCT03293485Phase 3Results posted
• Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic SurgeryCompletedNCT03287089Phase 4Results posted
• Closed Incision Negative Pressure Therapy Versus Standard of Care Surgical Dressing in Revision Total Knee ArthroplastyCompletedNCT03274466Not applicableResults posted
• Immunologic Responses to a Live Attenuated Oral Cholera VaccineCompletedNCT03251495Phase 2Results posted
• Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)CompletedNCT03244644Phase 3Results posted
• Vaccination Education Through Pharmacists and Senior Centers (VEPSC)CompletedNCT03239665Not applicableResults posted
• A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without RitonavirCompletedNCT03234036Phase 1Results posted
• Development of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT03233438Phase 4Results posted
• GSK3640254 First Time in Human (FTIH) Study in Healthy VolunteersCompletedNCT03231943Phase 1Results posted
• A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)CompletedNCT03230916Phase 1Results posted
• MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)CompletedNCT03230838Phase 2Results posted
• Study of Aztreonam for Inhalation in Children With Cystic Fibrosis and New Infection of the Airways by Pseudomonas Aeruginosa BacteriaTerminatedNCT03219164Phase 3Results posted
• MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)CompletedNCT03217136Phase 2Results posted
• Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)CompletedNCT03212989Phase 1Results posted
• Topical Antibiotic Prophylaxis for EyelidsCompletedNCT03199911Phase 4Results posted
• ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile InfectionCompletedNCT03183141Phase 3Results posted
• ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile InfectionCompletedNCT03183128Phase 3Results posted
• Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)CompletedNCT03182907Phase 3Results posted
• Clinical Trial of Efficacy and Safety of Anaferon for Children Liquid Dosage Form in the Treatment of Acute Upper Respiratory InfectionsCompletedNCT03162458Phase 3Results posted
• Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy SubjectsCompletedNCT03149848Phase 1Results posted
• Incidence and Risk Factors for Surgical Site Infection After Intramedullary Nailing of Femoral and Tibial FracturesCompletedNCT03148067Results posted
• Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes InfectionTerminatedNCT03146403Phase 2Results posted
• Rifaximin Associated With Classic Triple Therapy for the Eradication of Helicobacter Pylori InfectionCompletedNCT03124199Phase 3Results posted
• Project PROTECT: Protecting Nursing Homes From Infections and HospitalizationCompletedNCT03118232Phase 4Results posted
• Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)CompletedNCT03111108Phase 4Results posted
• VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and AdolescentsCompletedNCT03110770Phase 2Results posted
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. DiffCompletedNCT03110133Phase 2Results posted
• Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter InsertionCompletedNCT03101371Phase 2Results posted
• Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract InfectionCompletedNCT03099863Phase 4Results posted
• Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted InfectionsTerminatedNCT03098394Not applicableResults posted
• Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT03074331Phase 3Results posted
• Feasibility of SBIRT-PNCompletedNCT03057119Not applicableResults posted
• Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected AdultsCompletedNCT03045861Phase 2Results posted
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in ChildrenCompletedNCT03039699Phase 4Results posted
• Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in ChildrenCompletedNCT03039621Phase 4Results posted
• Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal DiseaseCompletedNCT03036839Phase 2Results posted
• Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract InfectionsCompletedNCT03032510Phase 3Results posted
• Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV InfectionCompletedNCT03022981Phase 2Results posted
• Tolerability, Safety, and Efficacy of Tedizolid as Oral Treatment for Bone and Joint Infections (OTTER)CompletedNCT03009045Phase 2Results posted
• Cryptococcal Antigen Screening Plus SertralineTerminatedNCT03002012Phase 3Results posted
• Cranberry Effect on Urinary Tract InfectionsCompletedNCT02996981Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated CirrhosisCompletedNCT02996682Phase 3Results posted
• Screening to Prophylax Against Clostridium Difficile Infection -CompletedNCT02996487Phase 4Results posted
• Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C CirrhosisCompletedNCT02994056Phase 2Results posted
• Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy OutcomesCompletedNCT02986802Results posted
• Evaluation of Moderate to Severe Influenza Outcomes in ChildrenCompletedNCT02979626Results posted
• Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract InfectionCompletedNCT02979431Phase 2Results posted
• Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC)CompletedNCT02971007Phase 2Results posted
• Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT02961764Phase 4Results posted
• Effect of Standard Normothermia Protocol On Surgical Site InfectionsCompletedNCT02961244Not applicableResults posted
• Rapid Diagnostics for Upper Respiratory Infections in the Emergency DepartmentCompletedNCT02957136Not applicableResults posted
• Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk AntibioticsCompletedNCT02951702Phase 4Results posted
• Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory CohortCompletedNCT02910037Not applicableResults posted
• Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSICompletedNCT02877927Phase 3Results posted
• Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's FootCompletedNCT02871011Phase 2Results posted
• Performance of Nucleic Acid Amplification Tests for the Detection of NG and CTCompletedNCT02870101Not applicableResults posted
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer ChemotherapyCompletedNCT02868242Phase 2Results posted
• Prevena™ vs Dermabond in Groin Wound Infections in Vascular SurgeryCompletedNCT02836990Not applicableResults posted
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)CompletedNCT02831764Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)CompletedNCT02831673Phase 3Results posted
• Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing RegimenCompletedNCT02822794Phase 3Results posted
• Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSACompletedNCT02814916Phase 3Results posted
• Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal InfectionsCompletedNCT02784704Phase 3Results posted
• Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver TransplantCompletedNCT02781571Phase 2Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and CirrhosisCompletedNCT02781558Phase 2Results posted
• Evaluating the Safety and Pharmacokinetics of Maraviroc in HIV-1-Exposed Infants at Risk of Acquiring HIV-1 InfectionCompletedNCT02778204Phase 1Results posted
• Topical Antibiotic Treatment for Spine Surgical Site InfectionCompletedNCT02776774Results posted
• Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP InfectionsCompletedNCT02753946Phase 2/3Results posted
• Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol UseCompletedNCT02744040Not applicableResults posted
• Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)CompletedNCT02739997Phase 3Results posted
• Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Participants With Chronic Genotype 2 HCV InfectionCompletedNCT02738333Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)CompletedNCT02738138Phase 3Results posted
• Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014)CompletedNCT02728089Phase 3Results posted
• Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus InfectionCompletedNCT02722837Phase 3Results posted
• Surgical Site Infections After Liver Transplantation Based on Perioperative AntibioticsCompletedNCT02717273Phase 3Results posted
• Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With MenCompletedNCT02716675Phase 2Results posted
• Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative PathogensCompletedNCT02714595Phase 3Results posted
• Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV TreatmentCompletedNCT02707601Phase 3Results posted
• A Comparison of Fidaxomicin and Vancomycin in Patients With CDI Receiving Antibiotics for Concurrent InfectionsCompletedNCT02692651Phase 4Results posted
• Effect of Peri-operative Supplemental Oxygen in Wound Infection After AppendectomyCompletedNCT02687217Not applicableResults posted
• Superficial and Cutaneous Fungal Infections Among Drug-users in Northeast Region of IranCompletedNCT02681458Results posted
• Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV InfectionCompletedNCT02664415Phase 2Results posted
• Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream InfectionCompletedNCT02651428Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 InfectionCompletedNCT02651194Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated CirrhosisCompletedNCT02642432Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 InfectionCompletedNCT02640482Phase 3Results posted
• Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and CirrhosisCompletedNCT02639338Phase 3Results posted
• Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma WoundsCompletedNCT02638298Not applicableResults posted
• Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy VolunteersCompletedNCT02631954Phase 1Results posted

← Communicable Diseases overview